Shalini Sharp - 21 May 2025 Form 4 Insider Report for NEUROCRINE BIOSCIENCES INC (NBIX)

Reporting relationship: Director
Issuer ticker: NBIX
Reported as of: 21 May 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 22 May 2025, 17:28:01 UTC
Prior SEC filing: 24 Oct 2024
Next SEC filing: 16 Jun 2025
Source filing: View source filing
Reporting owner signature: /s/ Darin Lippoldt, Attorney-in-Fact

Key filing fact

Shalini Sharp filed Form 4 for NEUROCRINE BIOSCIENCES INC (NBIX) on 22 May 2025.

Key facts

This page summarizes Shalini Sharp's Form 4 filing for NEUROCRINE BIOSCIENCES INC (NBIX).
4 reported transactions and 3 derivative rows are listed below.
Accepted by SEC: 22 May 2025, 17:28.

Change

Previous filing in this sequence was filed on 24 Oct 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001377202 Primary reporting owner

Sharp Shalini

Relationship: Director
Address: 6027 EDGEWOOD BEND COURT, SAN DIEGO
Signature: /s/ Darin Lippoldt, Attorney-in-Fact
Signature date: 22 May 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NBIX transaction

Common Stock

Options Exercise

Transaction value: $0
Shares: +1,435
Change %: +144%
Price: $0.000000
Shares after: 2,429
Date: 22 May 2025
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NBIX transaction Derivative

Restricted Stock Unit

Award

Transaction value: $0
Shares: +1,659
Change %
Price: $0.000000
Shares after: 1,659
Date: 21 May 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,659
Exercise price: $0.000000
Footnotes: F1, F2

NBIX transaction Derivative

Non-Qualified Stock Option

Award

Transaction value: $0
Shares: +3,305
Change %
Price: $0.000000
Shares after: 3,305
Date: 21 May 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 3,305
Exercise price: $120.56
Footnotes: F3

NBIX transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value: $0
Shares: -1,435
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 22 May 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,435
Exercise price: $0.000000
Footnotes: F1, F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's common stock upon vesting.

Footnote F2

The RSUs will vest in full on May 21, 2026.

Footnote F3

Option vests in 12 monthly installments beginning June 21, 2025.

Footnote F4

This RSU award was granted to the Reporting Person on May 22, 2024 and is fully vested.